2-(2-Amino-3-methylphenyl)propan-2-ol, 95%, 250mg

(S)-N-(2-PROPYNYL)-2,3-DIHYDROINDEN-1-AMINE, 97.0%, 250mg

5-Bromo-2,3-dihydroimidazo[1,2-a]pyrazine, 95+%, 250mg

Ethyl 2-(5,6-dimethyl-4-oxofuro[2,3-d]pyrimidin-3(4H)-yl)acetate, 95%, 250mg

2-(2-((tert-Butoxycarbonyl)amino)ethyl)thiazole-4-carboxylic acid, 1g

2-((3-Chlorophenyl)amino)-4-methyl-1,3-thiazole-5-carboxylic acid, 95%, 2g

2-Methoxy-4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 97%, 250mg

({[3-(trifluoromethyl)phenyl]methyl}sulfanyl)methanimidamide hydrobromide, 95.0%, 10g

3-Iodoquinoline, 95.0%, 1g

tert-Butyl 7-(trifluoromethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate, 95.0%, 250mg

6-Bromo[1,2,4]triazolo[1,5-a]pyridine-8-carbonitrile, 1g

Undecanoyl Chloride>97.0%(GC)(T)25mL

1,1,1,3,3,3-esafluoro-2-propanolo (HFIP), 25 ml, >=99%, per la sintesi di peptidi